Article

Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.

Department of Surgical Pathology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists (impact factor: 2.07). 04/2011; 30(3):231-5. DOI:10.1097/PGP.0b013e3182005340 pp.231-5
Source: PubMed

ABSTRACT This is the case report of a 38-year-old woman who presented with a mass of the right broad ligament that was diagnosed as a female adnexal tumor of probable Wollfian origin (FATWO). The patient was treated with a simple mass excision. Three years after the excision, the patient presented with uterine bleeding. A total abdominal hysterectomy was advised. Intraoperative histologic consultation showed a poorly differentiated tumor on the surface of the left ovary. After extensive immunohistochemistry analysis and after reviewing the histology slides from the primary tumor, the final diagnosis was concluded to be recurrent FATWO on the surface of the ovary. C-kit immunohistochemistry was found to be strongly positive. Polymerase chain reaction amplification of C-kit genes on exons 9, 11, 13, and 17 and of PDGFR gene on exons 12 and 18 showed no mutational changes. Owing to the limited options in treating recurrent disease and the lack of prognostic factors for recurrence or metastasis, the patient was started on 400 mg of imatinib mesylate therapy for 6 months. In addition, the patient is undergoing continuous follow-up by computed tomographic imaging every 6 months. As chemotherapy and radiation therapy for recurrent or metastatic FATWO are most often unsuccessful, a molecular targeted therapy, such as tyrosine kinase inhibitor, could be considered. However, collective data are needed from multiple centers to determine its effectiveness in these patients.

0 0
 · 
0 Bookmarks
 · 
71 Views

Keywords

38-year-old woman
 
6 months
 
C-kit genes
 
C-kit immunohistochemistry
 
computed tomographic imaging
 
extensive immunohistochemistry analysis
 
female adnexal tumor
 
final diagnosis
 
imatinib mesylate therapy
 
Intraoperative histologic consultation
 
left ovary
 
limited options
 
metastatic FATWO
 
patients
 
PDGFR gene
 
Polymerase chain reaction amplification
 
radiation therapy
 
recurrent FATWO
 
total abdominal hysterectomy
 
tyrosine kinase inhibitor
 

Susanna Syriac